| JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Accela sei ein Quantensprung in der Strahlentherapie... ► Artikel lesen |
| Siemens Healthineers Aktie: Neues Verkaufssignal macht Sorgen! | Die Siemens Healthineers Aktie hat ihre jüngste Erholung beendet. Nach der kleinen Rallye zwischen dem 23. Juli und dem 24. August, die den Kurs des Erlanger Medizintechnikkonzerns von 33,78 Euro auf... ► Artikel lesen |
| Buy or Goodbye?: Meta, Novo Nordisk, SAP & Siemens Healthineers - Die Analystenstimmen des Tages | © Foto: Uwe Anspach/dpaMeta, Novo Nordisk, SAP, Siemens Healthineers: Die wichtigsten Analysten-Updates im Überblick Enthaltene Werte: DE0007164600,US30303M1027,DE000SHL1006,DK0062498333Den vollständigen... ► Artikel lesen |
| Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen |
| Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen |
| Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen |
| Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen |
| Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen |
| Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance | First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year periodFirst Quarter Net income was $41.7 million compared to $5.2 million for the prior year periodAdjusted EBITDA for... ► Artikel lesen |